Antibiotic prescribing for presumed nonbacterial acute respiratory tract infections☆
To access this article, please choose from the options below
☆ Source of support: Dr Aspinall was a VA HSR&D Research Career Development Awardee (RCD 03-035) at the time of the study. Dr Fine was supported in part by a K-24 midcareer development award from the National Institute of Allergy and Infectious Diseases (5K24 A101769). Financial support was provided by a pilot grant through the Center for Health Equity Research and Promotion and an unrestricted educational grant from Pfizer, Inc. The Center for Health Equity Research and Promotion Intramural Review Committee and Pfizer, Inc, had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
Results were presented as a poster at the Health Services Research and Development National Meeting in Baltimore, MD, on February 17, 2005.
PII: S0735-6757(08)00325-2
doi:10.1016/j.ajem.2008.04.015
Published by Elsevier Inc.
